TePA-study (Tertiary Prevention of morbus Asherman-study);Evaluation of placement of hyaluronic acid (hyalobarier ® Gel Endo) and placement of a intrauterine device without cu or hormones to maintain separation of the cavity and mechanically to prevent spontaneous recurrence of adhesions.<br> - TePA-study (Tertiary Prevention of morbus Asherman-study)<br>

Spaarne Ziekenhuis0 个研究点目标入组 110 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•Consented patients with M. Asherman who had a successful hysteroscopic adhesiolysis, defined as a restore of the normal uterine cavity, are eligible for inclusion. Patients with M. Asherman should be defined as patients with any diminishing of blood flow (secondary amenorrhoea or secondary hypomenorrhoe) after trauma, hypoxia or infection to the uterine cavity due to pregnancy related surgical procedure with the presence of intrauterine adhesions with a previous history of normal menstrual blood flow.

•- Patients with a suspected M. Asherman due to tuberculosis or schitsosomiasis.
•- Patients with an uncorrected anovulation, amenorrhoe or oligomenorrhoe previous to the M. Asherman syndrome
•- Patients with suspected M. Asherman due to hysteroscopic surgery with the use of electrocoagulation (used in fibroid or polyp surgery)
•- Patients with congenital uterine anomalies
•- Patients with contraindications for a surgical adhesiolysis
•- Patients who do not master the Dutch or English language.
•- Patients who are younger than 18 years of age or mentally incompetent.
•- Patients with contraindications for Cu_IUD gel(hyalobarier ® Gel Endo)
•- Patients who use hormonal suppletion

发起方

Spaarne Ziekenhuis